{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:19:19Z","timestamp":1789532359259,"version":"build-2803163510"},"reference-count":44,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-47\/2023-01\/200019"],"award-info":[{"award-number":["451-03-47\/2023-01\/200019"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["337-00-107\/2019-09\/12"],"award-info":[{"award-number":["337-00-107\/2019-09\/12"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["APVV SK-SRB-21-0046"],"award-info":[{"award-number":["APVV SK-SRB-21-0046"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["VEGA 2\/0120\/22"],"award-info":[{"award-number":["VEGA 2\/0120\/22"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["APVV-20-0243"],"award-info":[{"award-number":["APVV-20-0243"]}]},{"name":"Bilateral Cooperation project with the Republic of Slovakia","award":["451-03-47\/2023-01\/200019"],"award-info":[{"award-number":["451-03-47\/2023-01\/200019"]}]},{"name":"Bilateral Cooperation project with the Republic of Slovakia","award":["337-00-107\/2019-09\/12"],"award-info":[{"award-number":["337-00-107\/2019-09\/12"]}]},{"name":"Bilateral Cooperation project with the Republic of Slovakia","award":["APVV SK-SRB-21-0046"],"award-info":[{"award-number":["APVV SK-SRB-21-0046"]}]},{"name":"Bilateral Cooperation project with the Republic of Slovakia","award":["VEGA 2\/0120\/22"],"award-info":[{"award-number":["VEGA 2\/0120\/22"]}]},{"name":"Bilateral Cooperation project with the Republic of Slovakia","award":["APVV-20-0243"],"award-info":[{"award-number":["APVV-20-0243"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease (CKD) is a global health concern affecting approximately one billion individuals worldwide. End-stage kidney disease (ESKD), the most severe form of CKD, is often accompanied by anemia. Peritoneal dialysis (PD), a common treatment for ESKD, utilizes the peritoneum for solute transfer but is associated with complications including protein loss, including transferrin (Tf) a key protein involved in iron transport. This study investigated Tf characteristics in ESKD patients compared to healthy individuals using lectin microarray, spectroscopic techniques and immunocytochemical analysis to assess Tf interaction with transferrin receptors (TfRs). ESKD patients exhibited altered Tf glycosylation patterns, evidenced by significant changes in lectin reactivity compared to healthy controls. However, structural analyses revealed no significant differences in the Tf secondary or tertiary structures between the two groups. A functional analysis demonstrated comparable Tf-TfR interaction in both PD and healthy samples. Despite significant alterations in Tf glycosylation, structural integrity and Tf-TfR interaction remained preserved in PD patients. These findings suggest that while glycosylation changes may influence iron metabolism, they do not impair Tf function. The study highlights the importance of a glucose-free dialysis solutions in managing anemia exacerbation in PD patients with poorly controlled anemia, potentially offering a targeted therapeutic approach to improve patient outcomes.<\/jats:p>","DOI":"10.3390\/ijms25094625","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:56:31Z","timestamp":1713930991000},"page":"4625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-8711","authenticated-orcid":false,"given":"Goran","family":"Milju\u0161","sequence":"first","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2539-4507","authenticated-orcid":false,"given":"Ana","family":"Penezi\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-2476","authenticated-orcid":false,"given":"Lucia","family":"Pa\u017eitn\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, 84538 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-2486","authenticated-orcid":false,"given":"Nikola","family":"Gligorijevi\u0107","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Technology and Metallurgy, Department of Chemistry, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5585-9793","authenticated-orcid":false,"given":"Marko","family":"Barali\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic of Nephrology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Viloti\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Biology of Reproduction, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-9481","authenticated-orcid":false,"given":"Milo\u0161","family":"\u0160underi\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-4645","authenticated-orcid":false,"given":"Dragana","family":"Robajac","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-7719","authenticated-orcid":false,"given":"Zorana","family":"Dobrijevi\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Katrl\u00edk","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, 84538 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-0056","authenticated-orcid":false,"given":"Olgica","family":"Nedi\u0107","sequence":"additional","affiliation":[{"name":"Institute for the Application of Nuclear Energy (INEP), Department for Metabolism, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Jafar","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc08-0779","article-title":"Anemia, Diabetes, and Chronic Kidney Disease","volume":"32","author":"Mehdi","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D.R. (2016). Global prevalence of chronic kidney disease\u2014A systematic review and meta-analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneph.2017.63","article-title":"Reducing the costs of chronic kidney disease while delivering quality health care: A call to action","volume":"13","author":"Vanholder","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","article-title":"The impact of chronic kidney disease on global health","volume":"16","author":"Carney","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_9","first-page":"213","article-title":"Chronic kidney disease and end-stage renal disease\u2014A review produced to contribute to the report \u2018the status of health in the European Union: Towards a healthier Europe\u2019","volume":"3","author":"Zoccali","year":"2010","journal-title":"NDT Plus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMra2100152","article-title":"Peritoneal dialysis","volume":"385","author":"Teitelbaum","year":"2021","journal-title":"New Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41598-018-19147-x","article-title":"Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients","volume":"8","author":"Ferrantelli","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3747\/pdi.2018.00138","article-title":"Peritoneal protein loss, leakage or clearance in peritoneal dialysis, where do we stand?","volume":"39","author":"Guedes","year":"2019","journal-title":"Periton Dial. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/pmic.201500551","article-title":"Mass spectrometry of transferrin glycoforms to detect congenital disorders of glycosylation: Site-specific profiles and pitfalls","volume":"16","author":"Wada","year":"2016","journal-title":"Proteomics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/glycob\/cwu033","article-title":"Structural change of N-glycan exposes hydrophobic surface of human transferrin","volume":"24","author":"Nagae","year":"2014","journal-title":"Glycobiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/rcm.1718","article-title":"Site-specific carbohydrate profiling of human transferrin by nano-flow liquid chromatography\/electrospray ionization mass spectrometry","volume":"18","author":"Satomi","year":"2004","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","article-title":"Iron homeostasis","volume":"69","author":"Andrews","year":"2007","journal-title":"Annu. Rev. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4157(96)00014-7","article-title":"The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells","volume":"1331","author":"Richardson","year":"1997","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Biomembr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/jimd.12273","article-title":"Screening for abnormal glycosylation in a cohort of adult liver disease patient","volume":"43","author":"Jansen","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1038\/srep33927","article-title":"Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease","volume":"6","author":"Tobler","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9111079","article-title":"Oxidative stress in ESRD patients on dialysis and the risk of cardiovascular diseases","volume":"9","author":"Rysz","year":"2020","journal-title":"Antioxidants"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0167-4838(01)00336-3","article-title":"UV-visible derivative spectroscopy under high pressure","volume":"1595","author":"Lange","year":"2002","journal-title":"Biochim. Biophys. Acta (BBA)-Protein Struct. Mol. Enzym."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2215\/CJN.01541005","article-title":"United States Iron Sucrose (Venofer) Clinical Trials Group. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: A randomized, controlled trial","volume":"1","author":"Singh","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Diao, X., Zheng, Z., Yi, C., Cao, P., Ye, H., Liu, R., Lin, J., Chen, W., Mao, H., and Huang, F. (2022). Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study. Nutrients, 14.","DOI":"10.3390\/nu14081613"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, S.Y., Chuang, C.L., Lin, C.C., Tsai, S.H., and Chen, J.Y. (2021). Peritoneal-Membrane Characteristics and Hypervolemia Management in Peritoneal Dialysis: A Randomized Control Trial. Membranes, 11.","DOI":"10.3390\/membranes11100768"},{"key":"ref_27","first-page":"108","article-title":"Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis","volume":"32","author":"Gallar","year":"2012","journal-title":"Nefrologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0896860819895364","article-title":"International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis","volume":"40","author":"Brown","year":"2020","journal-title":"Periton Dial. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jtbi.2016.05.024","article-title":"The effect of glycosylation on the transferrin structure: A molecular dynamic simulation analysis","volume":"404","author":"Ghanbari","year":"2016","journal-title":"J. Theor. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Rad. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11255-011-9947-4","article-title":"Transferrin changes in haemodialysed patients","volume":"44","author":"Formanowicz","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: Beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1399-3011.1977.tb03487.x","article-title":"Some observations on the carbohydrate composition of purified transferrin","volume":"9","author":"Wong","year":"1977","journal-title":"Int. J. Pept. Protein Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41420-023-01617-5","article-title":"New insight into protein glycosylation in the development of Alzheimer\u2019s disease","volume":"9","author":"Zhao","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"642296","DOI":"10.3389\/fmed.2021.642296","article-title":"Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents","volume":"8","author":"Broseta","year":"2021","journal-title":"Front. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cbpa.2009.07.022","article-title":"Determination of glycosylation sites and site-specific heterogeneity in glycoproteins","volume":"13","author":"An","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_39","unstructured":"Flickinger, M.C. Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, John Wiley & Sons, Inc.. [1st ed.]."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.1405355111","article-title":"An iron-regulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Haemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2017.05.013","article-title":"A microscale protocol for the isolation of transferrin directly from serum","volume":"471","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Barali\u0107, M., Gligorijevi\u0107, N., Brkovi\u0107, V., Katrl\u00edk, J., Pa\u017eitn\u00e1, L., \u0160underi\u0107, M., Milju\u0161, G., Penezi\u0107, A., Dobrijevi\u0107, Z., and Lau\u0161evi\u0107, M. (2020). Fibrinogen fucosylation as a prognostic marker of end-stage renal disease in patients on peritoneal dialysis. Biomolecules, 10.","DOI":"10.3390\/biom10081165"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fphys.2017.00450","article-title":"Protein phosphorylation and mineral binding affect the secondary structure of the Leucine-Rich Amelogenin Peptide","volume":"8","author":"Yamazaki","year":"2017","journal-title":"Front. Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:02Z","timestamp":1760106782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25094625"],"URL":"https:\/\/doi.org\/10.3390\/ijms25094625","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}